These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17129855)

  • 1. Stigma and social barriers to medication adherence with urban youth living with HIV.
    Rao D; Kekwaletswe TC; Hosek S; Martinez J; Rodriguez F
    AIDS Care; 2007 Jan; 19(1):28-33. PubMed ID: 17129855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).
    Peretti-Watel P; Spire B; Pierret J; Lert F; Obadia Y;
    AIDS Care; 2006 Apr; 18(3):254-61. PubMed ID: 16546787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
    Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
    AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV patient insight on adhering to medication: a qualitative analysis.
    Beusterien KM; Davis EA; Flood R; Howard K; Jordan J
    AIDS Care; 2008 Feb; 20(2):244-52. PubMed ID: 18293136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients and family care givers' experiences around highly active antiretroviral therapy (HAART).
    Sacajiu G; Raveis VH; Selwyn P
    AIDS Care; 2009 Dec; 21(12):1528-36. PubMed ID: 20024732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil.
    Abadía-Barrero CE; Castro A
    Soc Sci Med; 2006 Mar; 62(5):1219-28. PubMed ID: 16099573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART.
    Davies G; Koenig LJ; Stratford D; Palmore M; Bush T; Golde M; Malatino E; Todd-Turner M; Ellerbrock TV
    AIDS Care; 2006 Nov; 18(8):895-903. PubMed ID: 17012078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of antiretroviral adherence.
    Murphy DA; Marelich WD; Hoffman D; Steers WN
    AIDS Care; 2004 May; 16(4):471-84. PubMed ID: 15203415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-related knowledge and adherence to HAART.
    Weiss L; French T; Finkelstein R; Waters M; Mukherjee R; Agins B
    AIDS Care; 2003 Oct; 15(5):673-9. PubMed ID: 12959818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of HIV/AIDS patients who have excellent adherence to HAART.
    Malcolm SE; Ng JJ; Rosen RK; Stone VE
    AIDS Care; 2003 Apr; 15(2):251-61. PubMed ID: 12856346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inability to take medications openly at home: does it help explain gender disparities in HAART use?
    Sayles JN; Wong MD; Cunningham WE
    J Womens Health (Larchmt); 2006 Mar; 15(2):173-81. PubMed ID: 16536681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
    Park-Wyllie LY; Phillips EJ
    Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Take HAART: medication adherence in the era of highly active antiretroviral therapy.
    Allardice K
    Aust Nurs J; 2002 Apr; 9(9):19-21. PubMed ID: 12017049
    [No Abstract]   [Full Text] [Related]  

  • 17. Barriers to antiretroviral medication adherence in HIV-infected women.
    Roberts KJ; Mann T
    AIDS Care; 2000 Aug; 12(4):377-86. PubMed ID: 11091770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence for HIV positive women caring for children: in their own words.
    Wood SA; Tobias C; McCree J
    AIDS Care; 2004 Oct; 16(7):909-13. PubMed ID: 15385246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.
    Ware NC; Wyatt MA; Tugenberg T
    Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.